LRRCC1, or Leucine-Rich Repeat and Coiled-Coil Domain Containing 1, is a protein encoded by the gene LRRCC1 in humans. While the complete functional spectrum of LRRCC1 is not fully elucidated, proteins containing leucine-rich repeat (LRR) domains are typically involved in protein-protein interactions and have been implicated in a variety of cellular functions, including signal transduction, cell adhesion, DNA repair, and the regulation of gene expression.
The LRR domain is characterized by a series of tandem repeats, usually 20–29 amino acid residues in length, that form a horseshoe-shaped structure with a parallel β-sheet on the concave side and helical elements on the convex side. This conformation facilitates interactions with a diverse array of protein partners. The coiled-coil domain, on the other hand, is known to mediate protein dimerization and oligomerization, suggesting that LRRCC1 may participate in forming protein complexes.Given the structure of LRRCC1, it is plausible that this protein could function as a scaffold, bringing together multiple proteins to form signaling complexes. Such complexes could be vital for the transduction of signals from the cell surface to the interior, influencing cellular responses to environmental cues. Furthermore, the coiled-coil domain of LRRCC1 might be involved in maintaining the structural integrity of these complexes or mediating interactions with cytoskeletal elements, thus potentially influencing cell shape and motility.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels, which may indirectly influence pathways associated with LRRCC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), potentially affecting signaling pathways related to LRRCC1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, potentially affecting downstream pathways that could intersect with LRRCC1 functions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK, which could indirectly influence LRRCC1 through the MAPK/ERK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially affecting signaling pathways related to LRRCC1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, potentially impacting pathways associated with LRRCC1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which may indirectly affect LRRCC1 activity by modulating cellular growth and metabolism pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, potentially influencing LRRCC1 activity through cytoskeletal regulation. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
Inhibits Rac1, a GTPase involved in actin cytoskeleton organization, potentially affecting LRRCC1-associated pathways. | ||||||